Ning Liu

机构：Wannan Medical College, Tulane University, University of Shanghai for Science and Technology, University of Toronto, Ningxia University, Institute of Health Services and Policy Research, Ningxia Medical University, Shanghai Harbour Engineering Design & Research Institute, Shanghai Ocean University · ORCID：0000-0002-7009-9187

发表论文 291 篇 · 总被引 4473 次 · h-index 36

代表论文

• ACSL4 knockdown inhibits colorectal cancer progression through stimulating anti-tumor immunity (2025 · Neoplasia · 被引 12)
• Multiomics evaluation and machine learning optimize molecular classification, prediction of prognosis and immunotherapy response for ovarian cancer (2025 · Pathology - Research and Practice · 被引 6)
• Bireociclib plus fulvestrant for HR+/HER2- advanced female breast cancer progressed on or after endocrine therapy: phase 3 BRIGHT-2 study interim analysis (2025 · Nature Communications · 被引 5)
• FGFC1 overcomes Ara-C resistance in acute myeloid leukemia by inducing apoptosis and pyroptosis (2025 · Frontiers in Pharmacology · 被引 3)
• Adipose-derived stem cells (ADSCs)-derived DKK1 promotes cutaneous wound healing by inducing M2 macrophage polarization via PI3K/AKT and JNK activation (2025 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 被引 2)
• Design and synthesis of thiazole-based hydroxamate histone deacetylase inhibitors with potent antitumor efficacy by inducing apoptosis, pyroptosis and cell cycle arrest (2025 · Scientific Reports · 被引 2)